The plant in Kabul, Afghanistan, is proving to be a key factor in the regional supply market for Abacavir Sulphate drug substance. This Afghan manufacturing capability represents a substantial step beyond for the Afghan pharmaceutical business and provides a valuable opportunity to reduce reliance on outside supplies. The generation of this vital m